Can I read Cost-Effectiveness of Dapagliflozin in CKD on EtoBox?

Cost-Effectiveness of Dapagliflozin in CKD by dr.magedalshimy is a document available to read on EtoBox.

What is Cost-Effectiveness of Dapagliflozin in CKD about?

This study evaluates the cost-effectiveness of dapagliflozin as an add-on therapy to ramipril for chronic kidney disease (CKD) patients in Kuwait. Using a Markov model, the research found that dapagliflozin improved quality-adjusted life years (QALYs) and resulted in cost savings compared to ramipril alone. The findings suggest that dapagliflozin could reduce the financial burden of dialysis and transplantation in the Kuwaiti healthcare system.

Author

dr.magedalshimy

Language

EN